From 20 to 23 May 2025, the Brazilian International Medical Equipment Exhibition (HOSPITALAR), the most popular exhibition in the global medical industry, will take place at the São Paulo International Convention and Exhibition Centre. Organized by Informa Markets, this exhibition is the largest and most influential medical event in South America. It attracted more than 1,200 exhibitors and over 100,000 professional visitors from more than 70 countries, and covered the entire industry chain of medical devices, rehabilitation technology and pharmaceutical products. HOSPITALAR is often referred to as "the wind vane of the Latin American medical market". It is often referred to as the "wind vane of the Latin American medical market". Diagreat, a leading Chinese in vitro diagnostics company, presented a number of innovative products and attracted significant attention at the exhibition thanks to its technical expertise and global presence.
A wonderful appearance of Chinese intelligent manufacturing
Diagreat Bio showcased its diverse and cutting-edge product range at the exhibition. From advanced medical equipment offering excellent performance, to professional solutions and high-quality IVD raw materials, each product demonstrates Diagreat Bio's expertise and creativity. They demonstrate the company's rich heritage and robust capabilities in the field of in vitro diagnostics. These competitive products attracted international customers from all over the world, and the Diagreat Bio stand was packed with people stopping by to ask questions and discuss potential collaborations. The atmosphere was extremely lively.
As an IVD company dedicated to independent innovation, Diagreat Bio has established technological barriers throughout the entire industrial chain, from raw materials to equipment, gaining the favor of numerous potential partners and customers in the process. Through in-depth discussions and demonstrations with visiting customers, Diagreat Bio fully showcased its robust R&D capabilities and innovative prowess, presenting the world with the exceptional calibre and dynamic spirit of Chinese biotechnology enterprises.
Diagreat Bio has always regarded R&D and innovation as the driving force behind enterprise development, establishing a robust and experienced R&D team in the process. Diagreat Bio's core products have successfully obtained CE certification from the European Union, as well as strict certifications from Italy, Mexico, Venezuela, Ecuador and other countries. These certifications demonstrate the company's professionalism and technological expertise in the medical field. In addition, Diagreat Bio's marketing network covers more than 60 countries and regions worldwide, providing solid support for the company's expansion into the global market. Its products are widely recognized and highly praised around the world!
Writing a new chapter in the development of globalization together
This trip to the Brazil International Medical Device Exhibition has once again confirmed the wisdom of Diagreat Bio's strategy of 'defining technological innovation by clinical need'. From purely exporting equipment, to establishing technical standards with global partners and evolving from a traditional single-trade model to an industry ecosystem, Diagreat Bio is continuously innovating and exploring new cooperation models. The company is writing its own brilliant chapter in the global medical market, expanding the depth and breadth of its cooperation and striding forward to become a world-leading in vitro diagnostic enterprise.
